Skip to content
Research peptide

What is Semax?

Semax explained in plain English: what it is, what the research shows, side effects, legal status and dosage. There is no validated human dose, and this page doesn't invent one. Also called ACTH(4-10) analog, Met-Glu-His-Phe-Pro-Gly-Pro.

Semax is approved as a medicine in Russia but not by the FDA or in Europe. This page is educational; talk with a qualified healthcare professional before using any substance.

What is Semax?

Semax is a lab-made peptide of seven amino acids, developed in Russia in the 1980s. It is built from a piece of ACTH, a stress hormone, but it doesn’t act as a hormone.

In Russia it has been a prescription medicine since the 1990s, given as a nasal spray. Elsewhere it is sold online as a “nootropic,” a brain-boosting supplement.

What does Semax do?

In animal and lab studies, Semax raises BDNF, a protein that helps brain cells survive and form connections, and affects dopamine and serotonin signaling. Researchers think this explains its protective effects on the brain after stroke.

What does the research on Semax show?

Most human research comes from Russia, where trials in stroke patients reported better recovery. Those studies were mostly small, often not blinded, and many aren’t available in full in English.

There are no good Western trials showing Semax improves focus, memory or mood in healthy people.

Semax side effects and risks

Side effects reported in Russian use are mild, mainly nasal irritation. But its effects in healthy people using it long-term are unknown, and the FDA has flagged possible immune reactions to compounded Semax.

Products sold online as research chemicals aren’t checked for purity or strength.

Semax is approved only in Russia and some nearby countries, not by the FDA or the European Medicines Agency. In the US it is on the FDA’s list of compounding substances with safety concerns for outsourcing facilities.

In July 2026 an FDA advisory committee recommended allowing it in pharmacy compounding, but that is not an approval and the FDA still has to decide.

Semax dosage

Semax is approved only in Russia, as nasal drops, and is not approved by the FDA. This site does not list Russian label doses because they aren't available in an English official source we can verify.

There is no approved or validated human dose. This site does not repeat doses from forums, sellers or animal studies.

Medical disclaimer: this dosage information is for education only and comes from the source shown for each row. It is not medical advice and not a recommendation for you. Only a licensed prescriber who knows your health can decide whether Semax is right for you and at what dose. Don't start, change or stop a medicine based on this page, and don't use research peptides or unapproved drugs based on trial doses.

Frequently asked questions

What is Semax used for?

In Russia it is a prescription nasal spray for stroke and some cognitive and nerve disorders. Elsewhere it is sold online as a nootropic for focus and memory, which hasn't been proven in Western trials.

Is Semax approved in the US?

No. Semax is not approved by the FDA or the European Medicines Agency. In July 2026 an FDA advisory committee recommended allowing it in pharmacy compounding, but the FDA hasn't decided.

How is Semax taken?

It is made as a nasal spray or drops. Research peptide sellers also sell it as a powder.

Sources

  1. Alzheimer's Drug Discovery Foundation, Semax (Cognitive Vitality for Researchers)
  2. FDA, Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks
  3. NCPA (2026), FDA advisory committee nominates six peptides for pharmacies to compound

Last updated .

More peptide guides and calculators